Skip to Content
Merck
CN
  • Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line.

Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line.

STAR protocols (2021-01-14)
Nicolas Bery, Gilles Favre, Aurélien Olichon
ABSTRACT

Here, we provide a protocol for the selection of conformation-specific intracellular antibody degraders using a cell-based screening method. We applied this protocol to select antibody-based degraders targeting the active form of the small GTPase RHOB (i.e., RHOB-GTP) using an engineered H2882 cell line. The protocol can be used to study the function of RHOB active conformation in various cellular settings. This protocol can be broadly applied to select any kind of intracellular antibody degraders, regardless of conformational state. For complete details on the use and execution of this protocol, please refer to Bery et al. (2019).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Mowiol® 4-88, Mw ~31,000
Sigma-Aldrich
Monoclonal Anti-α-Tubulin antibody produced in mouse, clone DM1A, ascites fluid